US · Healthcare · Biotechnology
| Fund | Stake |
|---|---|
| Geode Capital Management, LLC | 0.03% |
| L1 Global Manager Pty Ltd | 0.03% |
| RiverNorth Capital Management, LLC | 0.02% |
| SkyView Investment Advisors, LLC | 0.01% |
| Heights Capital Management Inc | 0.00% |
| Lynx Capital Group LTD | 0.00% |
| Jane Street Group LLC | 0.00% |
| UBS Group AG | 0.00% |
| Document | Date |
|---|---|
| Current report (6-K) · Q4 2026 OTHER NOTABLE POINTS • On November 1, 2026, Dr. Ethan Shen resigned as a director and Chief Technology Officer of SL Science Holding Limited. • The | 2026-11-03 |
| Quarterly results (6-K) · Q2 2026 HEADLINE NUMBERS • Revenue for the six months ended June 30, 2026 was $1,386,608, up from $1,129,238 in the same period of 2025. • Gross profit was | 2026-10-26 |
| Current report (6-K) · Q3 2026 HEADLINE NUMBERS • Date: 24 September 2026. • The document is a Cayman Islands legal opinion concerning SL Science Holding Limited and its Nasdaq li | 2026-09-24 |
| Current report (6-K) · Q3 2026 OTHER NOTABLE POINTS • Vice President of Finance Johnson Lau submitted his resignation on August 24, 2026. • The board accepted the resignation, eff | 2026-09-01 |
| Current report (6-K) · Q3 2026 HEADLINE NUMBERS • On August 21, 2026, SL Science Holding Limited appointed TAAD LLP (“TAAD”) as its independent registered public accounting firm. | 2026-08-27 |
| Current report (6-K) · Q3 2026 OTHER NOTABLE POINTS • SL Science Holding Limited filed a Form 6-K with the U.S. Securities and Exchange Commission for the month of July 2026. • Th | 2026-07-10 |
| Annual report FY2026 (20-F) HEADLINE NUMBERS • SL Science Holding Limited completed its business combination on June 12, 2026; its ordinary shares began trading on Nasdaq under | 2026-06-18 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SL Science Holding Limited Ordinary Shares — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.